The value of serology testing to manage SARS-CoV-2 infections
Open Access
- 16 July 2020
- journal article
- editorial
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (2), 2002411
- https://doi.org/10.1183/13993003.02411-2020
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosisJournal of Medical Virology, 2020
- Connecting clusters of COVID-19: an epidemiological and serological investigationThe Lancet Infectious Diseases, 2020
- Risk factors for severity and mortality in adult COVID-19 inpatients in WuhanJournal of Allergy and Clinical Immunology, 2020
- Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive studyThe Lancet Infectious Diseases, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- The clinical dynamics of 18 cases of COVID-19 outside of Wuhan, ChinaEuropean Respiratory Journal, 2020
- Evolutionary history, potential intermediate animal host, and cross‐species analyses of SARS‐CoV‐2Journal of Medical Virology, 2020
- Staff safety during emergency airway management for COVID-19 in Hong KongThe Lancet. Respiratory Medicine, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020